Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses

PS Sullivan, AS Johnson, ES Pembleton… - The Lancet, 2021 - thelancet.com
The HIV epidemic in the USA began as a bicoastal epidemic focused in large cities but, over
nearly four decades, the epidemiology of HIV has changed. Public health surveillance data …

Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States

S Barua, R Greenwald, J Grebely, GJ Dore… - Annals of internal …, 2015 - acpjournals.org
The aim of this study was to systematically evaluate state Medicaid policies for the treatment
of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid …

[图书][B] WHO guidelines on hepatitis B and C testing

World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1

S Naggie, C Cooper, M Saag… - … England Journal of …, 2015 - Mass Medical Soc
Background Effective treatment for hepatitis C virus (HCV) in patients coinfected with human
immunodeficiency virus type 1 (HIV-1) remains an unmet medical need. Methods We …

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non …

JK Rockstroh, M Nelson, C Katlama, J Lalezari… - The lancet HIV, 2015 - thelancet.com
Summary Background Hepatitis C virus (HCV) infection is a leading cause of morbidity and
mortality in patients with HIV-1. The C-EDGE CO-INFECTION study assessed the efficacy …

[HTML][HTML] Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1

DL Wyles, PJ Ruane, MS Sulkowski… - … England Journal of …, 2015 - Mass Medical Soc
Background The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and
the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data …

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial

MS Sulkowski, JJ Eron, D Wyles, R Trinh, J Lalezari… - Jama, 2015 - jamanetwork.com
Importance Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C
virus (HCV) are at high risk for liver disease progression. However, interferon-based …

Whither syndemics?: Trends in syndemics research, a review 2015–2019

M Singer, N Bulled, B Ostrach - Global Public Health, 2020 - Taylor & Francis
As originally conceived, syndemics refers to complex epidemics involving two types of
adverse interaction–the clustering and interactions of two or more diseases or health …

Comorbidities in persons with HIV: the lingering challenge

AM Lerner, RW Eisinger, AS Fauci - Jama, 2020 - jamanetwork.com
The United States recently announced an initiative for ending the HIV epidemic in the United
States. 1 The initiative is a joint effort of agencies across the US Department of Health and …

Recommendations for the management of hepatitis C virus infection among people who inject drugs

J Grebely, G Robaeys, P Bruggmann, A Aghemo… - International Journal of …, 2015 - Elsevier
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …